- Country: Brazil
- Summary: Future and Eventual Acquisition of Human Use Drugs (Aristab, Bupropiona) that will be Used to Comply with Judicial Decisions, in Compliance with the Municipal Health Secretariat of Uberlandi ...
- BRT Ref No: 120300069
- Deadline: 23 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90210/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Future and eventual acquisition of Human Use Medicines (ARISTAB, Bupropiona) that will be used to comply with court decisions, in compliance with the Municipal Health Secretariat of Uberlandia.
UASG Code: 926922
Notice from: 03/06/202517:00 hs
Proposal Delivery: From 03/06/2025 to 08: 00hs
aripiprazole, concentration 10 mg
quantity: 8640
aripiprazole, concentration 15 mg
quantity: 9000
aripiprazole, concentration 20 mg
quantity: 2160
bupropion hydrochloride, concentration 150 mg, additional features releaseProlonged
Quantity: 9360
Bupropion Chloride, Concentration 300 mg
Quantity: 720
lithium carbonate, concentration 450 mg, additional characteristics prolonged release
quantity: 1440
cilostazole, concentration 100 mg
quantity: 4320
duloxetine, concentration 60 mg, pharmaceutical formSlow release microgranles
Quantity: 3920
Pioglitazone hydrochloride, concentration 30 mg
quantity: 720
tral hydrochloride, dosage 50 mg
quantity: 1440
trackbill, concentration 100 mg
quantity: 720
furate, concentration 10 mg
quantity: 1440
walrsartan, compositionAssociated with hydrochlorothiazide, anlodipino beesyl o, concentration 160 mg + 12.5 mg + 10 mg
quantity: 2160
Apixabana, concentration 5 mg
quantity: 20160
walrsartan, composition associated with the calcitrile, concentration 26 mg + 24 mg
quantity: 1440
walrsartanConcentration 103 mg + 97 mg
Quantity: 7200
esomeprazole, concentration 40 mg, additional characteristics prolonged release
Quantity: 2880
Citidine, active ingredient 5-monophosphate, associated with uridine 5-triphosphate, composition and with hydroxycobalamin acetate, concentration 2.5mg + 1.5mg +1mg
quantity: 7200
ezetimiba, concentration 10 ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINFuture and Eventual Acquisition of Human Use Drugs (Aristab, Bupropiona) that will be Used to Comply with Judicial Decisions, in Compliance with the Municipal Health Secretariat of Uberlandi ... - Brazil Tender
The STATE GOVERNMENT OF MINAS GERAIS, a Government sector organization in Brazil, has announced a new tender for Future and Eventual Acquisition of Human Use Drugs (Aristab, Bupropiona) that will be Used to Comply with Judicial Decisions, in Compliance with the Municipal Health Secretariat of Uberlandi .... This tender is published on BrazilTenders under BRT Ref No: 120300069 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
